Pretherapeutic Inflammation Predicts Febrile Neutropenia and Reduced Progression-Free Survival after First-Line Chemotherapy in SCLC
Author:
Publisher
S. Karger AG
Subject
Cancer Research,Oncology,Hematology
Reference28 articles.
1. Torre LA, Bray F, Siegel RL, et al.: Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. Kahnert K, Kauffmann-Guerrero D, Huber RM: SCLC - state of the art and what does the future have in store? Clin Lung Cancer 2016;17:325-333.
3. Kukec RR, Grabnar I, Vovk T, et al.: Febrile neutropenia in chemotherapy treated small-cell lung cancer patients. Radiol Oncol 2015;49:173-180.
4. Crawford J, Glaspy JA, Stoller RG, et al.: Final results of a placebo-controlled study of filgrastim in small-cell lung cancer: exploration of risk factors for febrile neutropenia. Support Cancer Ther 2005;3:36-46.
5. Bohlius J, Engert A: Antibiotics plus granulocyte colony-stimulating factor reduces febrile neutropenia in the first cycle of chemotherapy in people with small-cell lung cancer. Cancer Treat Rev 2006;32:234-238.
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing;Therapeutic Advances in Respiratory Disease;2023-01
2. Glasgow prognostic score for prediction of chemotherapy‐triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer;Thoracic Cancer;2021-05-03
3. Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses;Therapeutic Advances in Medical Oncology;2021-01
4. The Relation between Hemogram Parameters and Survival in Extensive-Stage Small Cell Lung Cancer;Oncology Research and Treatment;2019
5. Prätherapeutische Entzündungsmarker korrelieren mit febriler Neutropenie;InFo Onkologie;2018-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3